SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-006729
Filing Date
2022-05-03
Accepted
2022-05-03 08:00:37
Documents
77
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-20220331x10q.htm   iXBRL 10-Q 1049644
2 EX-10.1 hrmy-20220331xex10d1.htm EX-10.1 13785
3 EX-31.1 hrmy-20220331xex31d1.htm EX-31.1 16265
4 EX-31.2 hrmy-20220331xex31d2.htm EX-31.2 16839
5 EX-32.1 hrmy-20220331xex32d1.htm EX-32.1 9968
6 EX-32.2 hrmy-20220331xex32d2.htm EX-32.2 9464
  Complete submission text file 0001558370-22-006729.txt   5681261

Data Files

Seq Description Document Type Size
7 EX-101.SCH hrmy-20220331.xsd EX-101.SCH 51144
8 EX-101.CAL hrmy-20220331_cal.xml EX-101.CAL 64180
9 EX-101.DEF hrmy-20220331_def.xml EX-101.DEF 147024
10 EX-101.LAB hrmy-20220331_lab.xml EX-101.LAB 428373
11 EX-101.PRE hrmy-20220331_pre.xml EX-101.PRE 321262
71 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20220331x10q_htm.xml XML 924564
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 22884666
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences